Pulmonx (LUNG) Change in Receivables (2019 - 2025)
Pulmonx (LUNG) reported Change in Receivables of -$1.4 million for Q3 2025, down 492.76% year-over-year from $359000.0 in Q3 2024, and down 215.57% on a QoQ basis from $1.2 million in Q2 2025.
Pulmonx (LUNG) has 7 years of Change in Receivables data on file, last reported at -$1.4 million in Q3 2025.
- Quarterly Change in Receivables fell 492.76% year-over-year to -$1.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.3 million (up 70.96% YoY) and the FY2024 annual result came in at $1.3 million, down 57.86% from the prior year.
- Change in Receivables retreated to -$1.4 million in Q3 2025 per LUNG's latest filing, from $1.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $1.8 million in Q4 2023 and bottomed at -$1.4 million in Q3 2025.
- The 5-year median for Change in Receivables is $715000.0 (2023), against an average of $503421.1.
- The widest annual swing landed in 2023, when Change in Receivables surged 793.41%; it then plunged 492.76% in 2025.
- Tracing LUNG's Change in Receivables over 5 years: stood at -$387000.0 in 2021, then surged by 431.78% to $1.3 million in 2022, then soared by 37.23% to $1.8 million in 2023, then slipped by 1.19% to $1.7 million in 2024, then plunged by 180.99% to -$1.4 million in 2025.
- Per Business Quant, the three latest LUNG Change in Receivables figures stand at -$1.4 million (Q3 2025), $1.2 million (Q2 2025), and $721000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.41 Mn |
| Sep 30, 2025 | -1.41 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 721,000.00 |
| Mar 31, 2025 | 721,000.00 |
| Dec 31, 2024 | 1.74 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 359,000.00 |
| Sep 30, 2024 | 359,000.00 |
| Jun 30, 2024 | 571,000.00 |
| Jun 30, 2024 | 571,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | 1.76 Mn |
| Dec 31, 2023 | 1.76 Mn |
| Sep 30, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 715,000.00 |
| Jun 30, 2023 | 715,000.00 |
| Mar 31, 2023 | -531,000.00 |
| Mar 31, 2023 | -531,000.00 |
| Dec 31, 2022 | 1.28 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | -167,000.00 |
| Sep 30, 2022 | -167,000.00 |
| Jun 30, 2022 | 796,000.00 |
| Jun 30, 2022 | 796,000.00 |
| Mar 31, 2022 | 277,000.00 |
| Mar 31, 2022 | 277,000.00 |
| Dec 31, 2021 | -387,000.00 |
| Dec 31, 2021 | -387,000.00 |
| Sep 30, 2021 | 87,000.00 |
| Sep 30, 2021 | 87,000.00 |
| Jun 30, 2021 | 1.72 Mn |
| Jun 30, 2021 | 1.72 Mn |
| Mar 31, 2021 | 1.01 Mn |
| Mar 31, 2021 | 1.01 Mn |
| Dec 31, 2020 | -1.12 Mn |
| Dec 31, 2020 | -1.12 Mn |
| Sep 30, 2020 | 2.58 Mn |
| Sep 30, 2020 | 2.58 Mn |
| Jun 30, 2020 | -2.01 Mn |
| Jun 30, 2020 | -2.01 Mn |
| Mar 31, 2020 | -912,000.00 |
| Mar 31, 2020 | -912,000.00 |
| Dec 31, 2019 | 213,000.00 |
| Dec 31, 2019 | 213,000.00 |